Member Info for inanaco

banned
Tosh
lemoore
lozan
I think Goy ...
Smiler (wanderer on adfvn)
big ... ? he is also adfvn c7 will remember
yoda
mily mog i think took a hit
myself .............. won on appeal
ONW left because he pontificates .. and nobody listened to him
Bibio .. became Goosed
Ruck is Gazza

sparked off the Gang "mode"

whats up

or

whats app

CHELSEA7 Premium Member

Posts: 41,015

Price: 6.90

No Opinion

FULL ASK PAIDToday 10:53
20K....7P

Bunsie, is your Whats Up working??

i dont think Ivy has freebies ... i showed the post of him getting "wet" ... ie he took a loss

Tosh just full of it ... his 6p buys that he claimed he bought .. took him back to scancell on the plus market sp was 80p approx before share split ... James007 spotted that one .. fake trade

Onw did sell down at 27p years ago, but has retained a core holding ... he would be in profit as both of us bought in before the moditope RNS

whats app

or

whats up

c7 ...

so all the negatives about the Board of Directors has now switched

to a "buying Group" ... driving up the SP .........

has anyone considered .. they have lost the plot ?

Ivy has teamed up with Loz ... and if you read it .. Onw is in agreement ...

the What's Up group generated by a C7 error ... has gone Viral ...

I believe its Russian intelligence .... if you can't hack it .......... buy it

https://www.growthbusiness.co.uk/scancell-in-good-health-989992/

spin off ....

I hope it means Investors have woken up to the intrinsic value and won't give up the shares to the market .. purely based on Moral views of lack of transparency presented by others .............. in which case buyers have a problem ... they did not before as ADFVN promotions and the "crew" promoted this lack of information as a Negative ...

however as i reported i took advantage of that ... i hope others will to .......... its so dam cheap in fact one of those "negative campaigners even described it as "" Ludicrously cheap ""

tick tock

just so folks understand ....

The production facilities for the OXford vaccines .. are very similar to MRNA vaccines and DNA vaccines .. if the UK is building its own production ....... then it fits well with Scancell products ..

Exactly Bermuda .......... this is what we should be promoting ...

good find post rec

According to the presentation, the combo of GX-188E and Keytruda achieved a significant increase in ORR, compared to Keytruda alone. The ORR of 26 patients available for evaluation was 42.3 percent, and the disease control rate (DCR) was 57.7 percent. In particular, four patients (15.6 percent) had complete remission (CR), and seven patients (26.9 percent), partial remission (PR). Four (15.4 percent) had stable disease (SD) reaction without cancer progression, and 11 (42.3 percent), progressive disease (PD) reaction with cancer progression.

4 /26 ................... complete remission .... astonishing for late stage .

that still leaves 42% ........................ able to move to moditope

http://www.koreabiomed.com/news/articleView.html?idxno=8103

results ... April 2020

there could be so many reasons why Scancell are in silent mode .... example I recently posted about the great news that Genexine vaccine and Mercks keytruda came good ....... Merck will be well chuffed with that ......... maybe Merck now feel motivated to get behind Scancell .......... who Knows ? Scancell has already done the "collaboration bit" and we are now clinic ready ....

from 2016

SEONGNAM, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ:095700), a clinical stage biotechnology company developing innovative biologics, today announced that it has entered into a clinical research collaboration with Merck & Co., Inc. (NYSE:MRK), Kenilworth, NJ, USA (known as MSD outside the US and Canada), for the assessment of Genexine’s GX-188E, HPV therapeutic DNA vaccine, in combination with MSD’s anti-PD-1 therapy, Keytruda® (pembrolizumab), for the treatment of patients with HPV-induced cancers.

Under the terms of the agreement between Genexine and MSD, through a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, Genexine will conduct a Phase 1b/2a clinical trial to access safety and efficacy of the combination therapy, and MSD will provide clinical supplies of Keytruda and offer support to the study. The agreement also includes provision for potential expansion to include Phase III registration studies in the same indication. Additional details were not disclosed.

what would happen to the SP if Merck stood behind Scancell ?

hold your horses Balerno1 i did not say it was fine, what i said was its legal ........ we would all love updates but the updates that make a difference are "Price sensitive" ..... so why spend time worrying about information that is not. The point i am making folks are attacking the BOD and trying to portray them as incompetent especially on ADFVN .. for all sorts of reasons ...

A great character is Bumble ... ... Sky cricket ...

Cant see Ivy lasting to long at the crease .... bumsie ...

Ivy ...
I have not said a word about your "win" .... why would i ? you might only have £100 worth ...

"""" finds out someone has had a much better day he gets all upset""""

Poor Ivy having sold his shares for a loss after advising us all the share will fall along with his crew, because the market is lacking information

the market then does the exact opposite

amusing ..

Up 16.8% with no RNS ...

you cannot make this stuff up

But the Oxford researchers are not done. Aside from monitoring the Phase III participants for long-term, they plan to launch challenge trials by the end of the year, according to Hill.

https://endpts.com/astrazeneca-oxford-researchers-champion-a-one-two-punch-against-covid-19-in-first-human-study/